janus kinase jak 1 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
94
Structured Review
Cell Signaling Technology Inc
janus kinase jak 1
Janus Kinase Jak 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/janus+kinase+jak+1/Myelin+Basic+Protein+Mouse+mAb/pm37285884-51-2-28
Average 94 stars, based on 28 article reviews
Janus Kinase Jak 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/janus+kinase+jak+1/Myelin+Basic+Protein+Mouse+mAb/pm37285884-51-2-28
Average 94 stars, based on 28 article reviews
janus kinase jak 1 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: Wedelolactone induces natural killer cell activity and the improvement to bioavailability using polysaccharides from Ligustri Lucidi Fructus. Article Snippet: Wedelolactone (WDL) is the major bioactive component in Ecliptae Herba.. This present study investigated the effects of WDL on natural killer cell functions and possible underlying mechanisms.. It was proved that wedelolactone enhanced the killing ability of NK92-MI by upregulating the expression of perforin and granzyme B through the JAK/STAT signaling pathway. Article Title: Poly I:C enhances production of nitric oxide in response to interferon-γ via upregulation of interferon regulatory factor 7 in vascular endothelial cells. Article Snippet: Contents lists available at ScienceDirect Microvascular Research j ourna l homepage: www.e lsev ie r .com/ locate /ymvre Poly I:C enhances production of nitric oxide in response to interferon-γ via upregulation of interferon regulatory factor 7 in vascular endothelial cells Daiki Mori a, Naoki Koide b, Bilegtsaikhan Tsolmongyn b, Hiroshi Nagata a, Tsuyoshi Sano a, Toshiaki Nonami a, Takashi Yokochi b,⁎ a Department of Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan b Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan ⁎ Corresponding author at: Department of Microbi Medical University School of Medicine, Nagakute, Aichi 4 63 9187.. E-mail address: yokochi@aichi-med-u.ac.jp (T. Yokoch http://dx.doi.org/10.1016/j.mvr.2015.01.003 0026-2862/ Elsevier Inc. a b s t r a c t a r t i c l e i n f o |